1 Study Coverage
1.1 Castration Resistant Prostate Cancer Treatment Revenue in Castration Resistant Prostate Cancer Treatment Business (2017-2022) & (US$ Million) Introduction
1.2 Global Castration Resistant Prostate Cancer Treatment Outlook 2017 VS 2022 VS 2028
1.2.1 Global Castration Resistant Prostate Cancer Treatment Market Size for the Year 2017-2028
1.2.2 Global Castration Resistant Prostate Cancer Treatment Market Size for the Year 2017-2028
1.3 Castration Resistant Prostate Cancer Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Castration Resistant Prostate Cancer Treatment in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Castration Resistant Prostate Cancer Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Castration Resistant Prostate Cancer Treatment Market Dynamics
1.4.1 Castration Resistant Prostate Cancer Treatment Industry Trends
1.4.2 Castration Resistant Prostate Cancer Treatment Market Drivers
1.4.3 Castration Resistant Prostate Cancer Treatment Market Challenges
1.4.4 Castration Resistant Prostate Cancer Treatment Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Castration Resistant Prostate Cancer Treatment by Type
2.1 Castration Resistant Prostate Cancer Treatment Market Segment by Type
2.1.1 Hormonal Therapy
2.1.2 Adding An Anti-Androgen
2.1.3 Stopping An Anti-Androgen
2.1.4 Estrogens
2.1.5 Chemotherapy
2.1.6 Radiation Therapy
2.1.7 Others
2.2 Global Castration Resistant Prostate Cancer Treatment Market Size by Type (2017, 2022 & 2028)
2.3 Global Castration Resistant Prostate Cancer Treatment Market Size by Type (2017-2028)
2.4 United States Castration Resistant Prostate Cancer Treatment Market Size by Type (2017, 2022 & 2028)
2.5 United States Castration Resistant Prostate Cancer Treatment Market Size by Type (2017-2028)
3 Castration Resistant Prostate Cancer Treatment by Application
3.1 Castration Resistant Prostate Cancer Treatment Market Segment by Application
3.1.1 Hospital
3.1.2 Ambulatory Surgical Centers
3.2 Global Castration Resistant Prostate Cancer Treatment Market Size by Application (2017, 2022 & 2028)
3.3 Global Castration Resistant Prostate Cancer Treatment Market Size by Application (2017-2028)
3.4 United States Castration Resistant Prostate Cancer Treatment Market Size by Application (2017, 2022 & 2028)
3.5 United States Castration Resistant Prostate Cancer Treatment Market Size by Application (2017-2028)
4 Global Castration Resistant Prostate Cancer Treatment Competitor Landscape by Company
4.1 Global Castration Resistant Prostate Cancer Treatment Market Size by Company
4.1.1 Top Global Castration Resistant Prostate Cancer Treatment Companies Ranked by Revenue (2021)
4.1.2 Global Castration Resistant Prostate Cancer Treatment Revenue by Player (2017-2022)
4.2 Global Castration Resistant Prostate Cancer Treatment Concentration Ratio (CR)
4.2.1 Castration Resistant Prostate Cancer Treatment Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Castration Resistant Prostate Cancer Treatment in 2021
4.2.3 Global Castration Resistant Prostate Cancer Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Castration Resistant Prostate Cancer Treatment Headquarters, Revenue in Castration Resistant Prostate Cancer Treatment Business (2017-2022) & (US$ Million) Type
4.3.1 Global Castration Resistant Prostate Cancer Treatment Headquarters and Area Served
4.3.2 Global Castration Resistant Prostate Cancer Treatment Companies Revenue in Castration Resistant Prostate Cancer Treatment Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Castration Resistant Prostate Cancer Treatment Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Castration Resistant Prostate Cancer Treatment Market Size by Company
4.5.1 Top Castration Resistant Prostate Cancer Treatment Players in United States, Ranked by Revenue (2021)
4.5.2 United States Castration Resistant Prostate Cancer Treatment Revenue by Players (2020, 2021 & 2022)
5 Global Castration Resistant Prostate Cancer Treatment Market Size by Region
5.1 Global Castration Resistant Prostate Cancer Treatment Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Castration Resistant Prostate Cancer Treatment Market Size by Region (2017-2028)
5.2.1 Global Castration Resistant Prostate Cancer Treatment Market Size by Region: 2017-2022
5.2.2 Global Castration Resistant Prostate Cancer Treatment Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Castration Resistant Prostate Cancer Treatment Market Size YoY Growth 2017-2028
6.1.2 North America Castration Resistant Prostate Cancer Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Castration Resistant Prostate Cancer Treatment Market Size YoY Growth 2017-2028
6.3.2 Europe Castration Resistant Prostate Cancer Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Castration Resistant Prostate Cancer Treatment Market Size YoY Growth 2017-2028
6.4.2 Latin America Castration Resistant Prostate Cancer Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Castration Resistant Prostate Cancer Treatment Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Castration Resistant Prostate Cancer Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Active Biotech
7.1.1 Active Biotech Company Details
7.1.2 Active Biotech Business Overview
7.1.3 Active Biotech Castration Resistant Prostate Cancer Treatment Introduction
7.1.4 Active Biotech Revenue in Castration Resistant Prostate Cancer Treatment Business (2017-2022)
7.1.5 Active Biotech Recent Development
7.2 Diagnocure
7.2.1 Diagnocure Company Details
7.2.2 Diagnocure Business Overview
7.2.3 Diagnocure Castration Resistant Prostate Cancer Treatment Introduction
7.2.4 Diagnocure Revenue in Castration Resistant Prostate Cancer Treatment Business (2017-2022)
7.2.5 Diagnocure Recent Development
7.3 Glaxosmithkline
7.3.1 Glaxosmithkline Company Details
7.3.2 Glaxosmithkline Business Overview
7.3.3 Glaxosmithkline Castration Resistant Prostate Cancer Treatment Introduction
7.3.4 Glaxosmithkline Revenue in Castration Resistant Prostate Cancer Treatment Business (2017-2022)
7.3.5 Glaxosmithkline Recent Development
7.4 Northwest Biotherapeutics
7.4.1 Northwest Biotherapeutics Company Details
7.4.2 Northwest Biotherapeutics Business Overview
7.4.3 Northwest Biotherapeutics Castration Resistant Prostate Cancer Treatment Introduction
7.4.4 Northwest Biotherapeutics Revenue in Castration Resistant Prostate Cancer Treatment Business (2017-2022)
7.4.5 Northwest Biotherapeutics Recent Development
7.5 Millennium Pharmaceuticals
7.5.1 Millennium Pharmaceuticals Company Details
7.5.2 Millennium Pharmaceuticals Business Overview
7.5.3 Millennium Pharmaceuticals Castration Resistant Prostate Cancer Treatment Introduction
7.5.4 Millennium Pharmaceuticals Revenue in Castration Resistant Prostate Cancer Treatment Business (2017-2022)
7.5.5 Millennium Pharmaceuticals Recent Development
7.6 Hologic
7.6.1 Hologic Company Details
7.6.2 Hologic Business Overview
7.6.3 Hologic Castration Resistant Prostate Cancer Treatment Introduction
7.6.4 Hologic Revenue in Castration Resistant Prostate Cancer Treatment Business (2017-2022)
7.6.5 Hologic Recent Development
7.7 Spectrum Pharmaceuticals
7.7.1 Spectrum Pharmaceuticals Company Details
7.7.2 Spectrum Pharmaceuticals Business Overview
7.7.3 Spectrum Pharmaceuticals Castration Resistant Prostate Cancer Treatment Introduction
7.7.4 Spectrum Pharmaceuticals Revenue in Castration Resistant Prostate Cancer Treatment Business (2017-2022)
7.7.5 Spectrum Pharmaceuticals Recent Development
7.8 Abbott Laboratories
7.8.1 Abbott Laboratories Company Details
7.8.2 Abbott Laboratories Business Overview
7.8.3 Abbott Laboratories Castration Resistant Prostate Cancer Treatment Introduction
7.8.4 Abbott Laboratories Revenue in Castration Resistant Prostate Cancer Treatment Business (2017-2022)
7.8.5 Abbott Laboratories Recent Development
7.9 Bayer Healthcare Pharmaceuticals
7.9.1 Bayer Healthcare Pharmaceuticals Company Details
7.9.2 Bayer Healthcare Pharmaceuticals Business Overview
7.9.3 Bayer Healthcare Pharmaceuticals Castration Resistant Prostate Cancer Treatment Introduction
7.9.4 Bayer Healthcare Pharmaceuticals Revenue in Castration Resistant Prostate Cancer Treatment Business (2017-2022)
7.9.5 Bayer Healthcare Pharmaceuticals Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
